Menu

CDC Director Takes a $165,300 Pay Cut

Robert Redfield’s record-setting salary was nearly double that of his predecessors.

May 9, 2018
Diana Kwon

WIKIMEDIA, JAVERT2113

Robert Redfield, the new director for the Centers for Disease Control and Prevention (CDC), has agreed to have his controversial $375,000 salary reduced to $209,700, Caitlin B. Oakley, a spokesperson for the Department of Health and Human Services (HHS), told reporters yesterday (May 8).

“Dr. Redfield did not want his compensation to become a distraction from the important work of the C.D.C. and asked that his salary be reduced,” Oakley said, according to The New York Times. “Dr. Redfield is being paid in accordance with the formula used to pay the prior three C.D.C. directors.”

According to the Times, Redfield’s initial pay was granted through Title 42, a provision that allows HHS to offer salaries higher than the approved government rates to scientists who possess exceptional qualities.

After being assigned the role of director in March, Redfield was granted a salary that was almost double that of his predecessors. According to The Washington Post, the last two directors, Brenda Fitzgerald and Thomas Frieden, received $193,700 and $219,700, respectively.

Redfield’s initial salary “is an exceptional amount of money for what we’ve seen in the past for (CDC) directors,” Angela Beck, a University of Michigan researcher who studies public health workforce issues, told the Associated Press in April.

On April 26, shortly after news reports revealed Redfield’s salary, Senator Patty Murray (D-Wash) penned a letter to HHS Secretary Alex Azar inquiring why Redfield was receiving significantly higher pay than his predecessors, other public health officials, and his boss. “It is difficult to understand why someone with limited public health experience, particularly in a leadership role, is being disproportionately compensated for his work as compared to other accomplished scientists and public health leaders in comparable roles within the federal government,” she wrote.

A few days later, HHS stated that Redfield was pushing to have his salary reduced.

See “AIDS Researcher Emerges as Top Candidate to Head CDC

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing